RecallDepth
Class III Terminated

BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC 59746-758-90) bottles, Rx only, Manufactured b Jubilant Generis Ltd, Roorkee, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD

Company
Jubilant Cadista Pharmaceuticals, Inc.
Recall Initiated
February 28, 2019
Posted
March 13, 2019
Recall Number
D-0519-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 3,072 bottles; b) 2,688 bottles
Firm Location
Salisbury, MD, United States

Reason for Recall

Failed Dissolution Specifications; 9-monthstability timepoint

Distribution

Product was distributed to one customer who may have further distributed the product.

Lot / Code Info

a) BR117002C, exp. date 11/2019; b) BR117003B and BR117004B, exp. date 11/2019

More recalls by Jubilant Cadista Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls